Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Synopsys, Inc. (SNPS) Price & Performance

Synopsys, Inc.Trade

Price performance (Past 24H)

Key statistics

Alcon AG vs Synopsys, Inc. — how do they compare? Alcon AG trades at $74.19 (market cap $36.44B), while Synopsys, Inc. trades at $410.9 (market cap $78.68B). The key difference: Synopsys, Inc. is far larger — about 2.2× Alcon AG's market cap, and Alcon AG pays a 0.48% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.

ALCSNPS
Market Cap
$36.44B$78.68B
Sector
HealthTechnology
52-Week High
$90.12$625.80
52-Week Low
$62.02$372.33
Enterprise Value
$40.28B$87.04B
Dividend Yield
0.48%

Returns comparison

Trailing returns across standard periods

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Synopsys, Inc.

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Read more on SNPS